Charlson comorbidity index has no incremental value for mortality risk prediction in nursing home residents with COVID-19 disease.

Publication date: Jan 30, 2025

During the COVID-19 pandemic, nursing home (NH) residents faced the highest risk of severe COVID-19 disease and mortality. Due to their frailty status, comorbidity burden can serve as a useful predictive indicator of vulnerability in this frail population. However, the prognostic value of these cumulative comorbidity scores like the Charlson comorbidity index (CCI) remained unclear in this population. We evaluated the incremental predictive value of the CCI for predicting 28-day mortality in NH residents with COVID-19, compared to prediction using age and sex only. We included older individuals of ≥ 70 years of age in a large retrospective observational cohort across NHs in the Netherlands. Individuals with PCR-confirmed COVID-19 diagnosis from 1 March 2020 to 31 December 2021 were included. The CCI score was computed by searching for the comorbidities recorded in the electronic patient records. All-cause mortality within 28 days was predicted using logistic regression based on age and sex only (base model) and by adding the CCI to the base model (CCI model). The predictive performance of the base model and the CCI model were compared visually by the distribution of predicted risks and area under the receiver operator characteristic curve (AUROC), scaled Brier score, and calibration slope. A total of 4318 older NH residents were included in this study with a median age of 88 years [IQR: 83-93] and a median CCI score of 6 [IQR: 5-7]. 1357 (31%) residents died within 28 days after COVID-19 diagnosis. The base model, with age and sex as predictors, had an AUROC of 0. 61 (CI: 0. 60 to 0. 63), a scaled brier score of 0. 03 (CI: 0. 02 to 0. 04), and a calibration slope of 0. 97 (CI: 0. 83 to 1. 13). The addition of CCI did not improve these predictive performance measures. The addition of the CCI as a vulnerability indicator did not improve short-term mortality prediction in NH residents. Similar (high) age and number of comorbidities in the NH population could reduce the effectiveness of these predictors, emphasizing the need for other population-specific predictors that can be utilized in the frail NH residents.

Open Access PDF

Concepts Keywords
88years Charlson comorbidity index
December COVID‐19
Nursing Frailty
Pandemic Nursing home population
Pcr Older people
Prognosis research
Vulnerability

Semantics

Type Source Name
disease MESH comorbidity
disease MESH COVID-19
disease MESH frailty
pathway REACTOME Reproduction
disease MESH functional independence
disease MESH death
drug DRUGBANK Trestolone
disease MESH infection
disease MESH liver disease
drug DRUGBANK Saquinavir
disease MESH Dementia
disease MESH heart failure
disease MESH tics
disease MESH COPD
disease MESH Chronic kidney disease
disease MESH Myocardial infarction
disease MESH Peripheral vascular disease
disease MESH Cerebrovascular accident
disease MESH Connective tissue disease
disease MESH Peptic ulcer
disease MESH Paralysis
disease MESH tumor
disease MESH Leukemia
disease MESH Lymphoma
drug DRUGBANK Esomeprazole
drug DRUGBANK Coenzyme M
disease MESH pneumonia
disease MESH influenza
disease IDO history
disease MESH nutritional status
disease IDO acute infection
drug DRUGBANK Ethionamide
drug DRUGBANK (S)-Des-Me-Ampa
disease IDO facility
drug DRUGBANK Diflunisal
drug DRUGBANK Tricyclazole
disease MESH Obesity
disease MESH chronic illness
disease MESH morbidities

Original Article

(Visited 1 times, 1 visits today)